Sanara MedTech Inc. Announces that it has Closed an Exclusive Affiliation with Precision Healing Inc.
FORT WORTH, TX / ACCESSWIRE / November 13, 2020 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech...
Year: 2020
Theralase Technology Demonstrates High Kill Rate of Coronavirus (BSL-2)
TORONTO, ON / ACCESSWIRE / November 13, 2020 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT) (OTCQB:TLTFF), a clinical...
Jupiter Wellness Initiates Clinical Trial for CaniDermRx in the Treatment of First Degree Burns
Study data to be used in planned IND filing with U.S. FDA JUPITER, FL / ACCESSWIRE / November 13, 2020...
ContraFect Reports Third Quarter 2020 Financial Results and Provides Business Update
CARB-X and Cystic Fibrosis Foundation grants provide significant additional funding to advance CF-370 for Pseudomonas aeruginosa infections Initiated expanded access...
Leading Adolescent Psychiatrists Join Evolve Treatment Centers
This group of world-class clinical leaders brings comprehensive behavioral health expertise to the excellent clinical programming offered at Evolve. LOS...
Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
BURNABY, British Columbia, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced...
Vaccinex Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Additional data from SIGNAL Huntington’s disease (HD) trial support continued development in HD and in Alzheimer’s disease (AD) Phase 1/2...
Greenwich Biosciences to Present Analysis of Three Clinical Studies of Nabiximols for People with Multiple Sclerosis Related Spasticity at the American Academy of Physical Medicine and Rehabilitation (AAPM&R) Annual Assembly
- Results from analysis of three Phase 3 clinical studies showed statistically significant improvement in spasticity in people with multiple...
New Study Finds Psychedelic Treatments More Effective than Typical Antidepressant Medications
NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Cybin Inc. (NEO: CYBN) announces the availability of a broadcast...
Avricore Health Closes $626,000 First Tranche of Financing
VANCOUVER, British Columbia, Nov. 13, 2020 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) announces it...
Preliminary Data from Real-World Study Demonstrate T-cell Testing Outperforms Antibody Testing in Identifying Past SARS-CoV-2 Infections
– Findings support upcoming launch of T-Detect™ COVID, first T-cell test for novel coronavirus– Data support mounting evidence that measuring...
NGM Bio Presents Phase 1 Safety and Pharmacokinetics Data for NGM621, an Anti-Complement C3 Antibody, in Patients with Geographic Atrophy at the American Academy of Ophthalmology 2020 Virtual
--Single and multiple intravitreal injections of NGM621 appeared safe and well tolerated in first-in-human study, with no patients experiencing serious...
New Phase 3 Data at AASLD Show Durable Response to Odevixibat in a Rare Pediatric Liver Disease
- PEDFIC 1 meets both U.S. and EU primary and secondary endpoints with highly statistically significant reductions in serum bile...
Assembly Biosciences Presents Data from HBV Core Inhibitor Programs in Poster Sessions at the 2020 AASLD The Liver Meeting Digital Experience™
- Data show longer-term, differentiated safety profile of vebicorvir and the importance of HBV pregenomic (pg) RNA as a key...
CalciMedica Announces Publication of Preclinical Data Demonstrating the Pathological Role of Microglial CRAC Channels in Ischemic Stroke
First report of pathological role for microglial calcium activity in cortical spreading depolarization (CSD), a complication of stroke CRAC channel...
Algernon Pharmaceuticals Provides Update on its Ifenprodil Phase 2 Clinical Trials Featured on BioPub Webcast Hosted by Dr. KSS MD PhD
VANCOUVER, British Columbia, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or...
CHMP recommends EU approval of Roche’s Phesgo (fixed-dose combination of Perjeta and Herceptin for subcutaneous injection) for HER2-positive breast cancer
Phesgo offers faster and less invasive delivery of standard of care treatment with Perjeta and Herceptin, under the skin in...
Aditxt Provides Business Update and Files Third Quarter 2020 10-Q
Mountain View, CA, Nov. 13, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX),...
GBT Announces Participation at the Stifel 2020 Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it...
PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
U.S. Food and Drug Administration (FDA) clearance of PMV Pharmaceutical’s investigational new drug application for its lead product candidate PC14586...